ArticleAmerican journal of cancer research2023

LMNTD2-AS1 regulates immune cell infiltration and promotes prostate cancer progression by targeting FUS to regulate NRF2 signal pathway.

Haoming Wu et al.PubMed ↗Full text ↗

No numbers read from the abstract.